{"id":88,"date":"2011-04-13T19:56:14","date_gmt":"2011-04-13T17:56:14","guid":{"rendered":"http:\/\/www.awametox.se\/?page_id=88"},"modified":"2016-02-04T19:15:01","modified_gmt":"2016-02-04T18:15:01","slug":"selected-publications-and-lectures-by-alf-claesson","status":"publish","type":"page","link":"https:\/\/awametox.se\/?page_id=88","title":{"rendered":"Selected publications and lectures by Alf Claesson"},"content":{"rendered":"<p>A Claesson. On the mechanism of paracetamol\u2019s analgesic activity and a note on related NSAID pharmacology. Manuscript published on <a href=\"http:\/\/www.slideshare.net\/aclaesson\/paracetamol-mechanism-on-slide-share-39192733\">http:\/\/www.slideshare.net\/aclaesson\/paracetamol-mechanism-on-slide-share<\/a>.<\/p>\n<p>A Claesson, O Spjuth. <a href=\"http:\/\/eurekaselect.com\/108113\/article\" target=\"_blank\">On Mechanisms of Reactive Metabolite Formation from Drugs<\/a>. <em>Mini-Rev Med Chem <\/em> 2013, <strong>13<\/strong>, 720-9.<\/p>\n<p>A Claesson. Increased drug safety &#8211; avoiding reactive metabolites. Presentation published 2012 on <a href=\"http:\/\/www.slideshare.net\/aclaesson\/increased-drug-safety-avoiding-reactive-metabolites\" target=\"_blank\">Slideshare<\/a>.<\/p>\n<p>Thompson RA, Isin EM, Li Y, Weaver R, Weidolf L, Wilson I, Claesson A, Page K, Dolgos H, Kenna JG. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21074519\">Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development.<\/a> <em>Chem Biol Interact<\/em>. 2010 Nov 11.<\/p>\n<p>A Claesson. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19350769\">[New analgesics coming. Monoclonal NGF antibody takes the lead].<\/a> In Swedish. <em>L\u00e4kartidningen<\/em>. 2009 Feb 11-17;106(7):430-4. Review.<\/p>\n<p>Baraznenok IL, Jonsson E, Claesson A. 3-(2,5-Dihydro-1H-pyrrol-2-ylmethoxy)pyridines: synthesis and analgesic activity. <em>Bioorg Med Chem Lett.<\/em> 2005, <strong>15<\/strong>, 1637-40.<\/p>\n<p>Lead author of textbook: A Claesson, B Danielsson, U Svensson. [<a href=\"http:\/\/www.lma-books.se\/9197431877-p-86.html\">Medicinal Chemistry<\/a>]. In Swedish. Apotekarsocieteten 2005 (3<sup>rd<\/sup> ed.), 490 pages.<\/p>\n<p>Lecture \u201cMolecular approaches toward new analgesics\u201d at <em>SMi Conference on Pain Therapeutics<\/em>, London, June 12-13, 2006<\/p>\n<p>Swahn BM, Edvinsson KM, Kallin E, Larsson U, Berge OG, Molin H, Pelcman B, Claesson A. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9377089\">Two non-racemic preparations of a piperidine-based NMDA antagonist with analgesic activity.<\/a> <em>Bioorg Med Chem<\/em>. 1997, <strong>5<\/strong>(7):1293-9<\/p>\n<p>S M Hammond, A Claesson, A M Jansson, L-G Larsson, B G Pring, C M Town, B Ekstr\u00f6m. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis. <em>Nature<\/em> 1987, <strong>327<\/strong>, 730-2.<\/p>\n<p>A Claesson, A M Jansson, B G Pring, S M Hammond, B Ekstr\u00f6m. Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analogue as novel antibacterial agents acting on lipopolysaccharide biosynthesis. <em>J. Med. Chem.<\/em> <strong>30<\/strong>, 2309-13 (1987).<\/p>\n<p>C Sahlberg, A Quader, A Claesson. Synthesis of conjugated dienes by nickel-catalyzed reactions of 1,3-alkadien-2-yl phosphates with Grignard reagents. <em>Tetrahedr. Lett.<\/em> <strong>24<\/strong>, 5137-5138 (1983).<\/p>\n<p>A Krantz, B Kokel, A Claesson et al. Allenic amines as inactivators of mitochondrial monoamine oxidase. In Kalman (ed.), Drug Action and Design: <em>Mechanism-based Enzyme Inhibitors<\/em>. Elsevier North 1979.<\/p>\n<p>Donald C. Booth, Thomas W. Phillips, Alf Claesson, Robert M. Silverstein, Gerald N. Lanier and Janet R. West. <a href=\"http:\/\/www.springerlink.com\/index\/Q37T22RQ32N47N54.pdf\">Aggregation pheromone components of two species of Pissodes weevils (Coleoptera: Curculionidae) Isolation, identification, and field activity<\/a>. <em>J Chem Ecol,<\/em> 1983, <strong>9<\/strong>, 1-12.<\/p>\n<p>A Krantz,\u00a0 B Kokel, A Claesson, C Sahlberg.\u00a0 <a href=\"http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jo01309a043\">An unusually selective photochemical reaction of a flavin<\/a>. <em>J. Org. Chem<\/em>., 1980, <strong>45<\/strong> , 4245\u20134248.<\/p>\n<p>Christer Sahlberg, Svante B. Ross, Ingrid Fagervall, Anna Lena Ask, Alf Claesson. <strong>S<\/strong>ynthesis and monoamine oxidase inhibitory activities of .alpha.-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes. <a href=\"http:\/\/dx.doi.org\/10.1021\/jm00361a017\"><em>J. Med. Chem.<\/em>, 1983<\/a>, <strong>26<\/strong> (7), pp 1036\u20131042.<\/p>\n<p>A Claesson, L-I Olsson. <a href=\"http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ja00518a028?prevSearch=%2528claesson+allenic%2529+AND+%255Bauthor%253A+Claesson%252C+Alf%255D+NOT+%255Batype%253A+ad%255D+NOT+%255Batype%253A+acs-toc%255D&amp;searchHistoryKey=\">Allenes and acetylenes. 22. Mechanistic aspects of the allene-forming reductions (SN2&#8242; reaction) of chiral propargylic derivatives with hydride reagents<\/a>. <em>J . Am. Chem. Soc.<\/em>, <strong>1979<\/strong>, 101 (24), pp 7302\u20137311.<\/p>\n<p><a href=\"http:\/\/media.awametox.se\/2011\/04\/bjork.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-102\" title=\"bjork\" src=\"http:\/\/media.awametox.se\/2011\/04\/bjork.jpg\" alt=\"\" width=\"432\" height=\"753\" srcset=\"https:\/\/awametox.se\/wp-content\/uploads\/2011\/04\/bjork.jpg 432w, https:\/\/awametox.se\/wp-content\/uploads\/2011\/04\/bjork-172x300.jpg 172w\" sizes=\"auto, (max-width: 432px) 100vw, 432px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Claesson. On the mechanism of paracetamol\u2019s analgesic activity and a note on related NSAID pharmacology. Manuscript published on http:\/\/www.slideshare.net\/aclaesson\/paracetamol-mechanism-on-slide-share. A Claesson, O Spjuth. On Mechanisms of Reactive Metabolite Formation from Drugs. Mini-Rev Med Chem 2013, 13, 720-9. A Claesson. Increased drug safety &#8211; avoiding reactive metabolites. Presentation published 2012 on Slideshare. Thompson RA, Isin&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-88","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/pages\/88","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/awametox.se\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=88"}],"version-history":[{"count":17,"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/pages\/88\/revisions"}],"predecessor-version":[{"id":165,"href":"https:\/\/awametox.se\/index.php?rest_route=\/wp\/v2\/pages\/88\/revisions\/165"}],"wp:attachment":[{"href":"https:\/\/awametox.se\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=88"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}